Synonyms: KW 2449; KW-2449; (E)-(4-(2-(1H-Indazol-3-yl)vinyl)-phenyl)(piperazin-1-yl)methanone; (E)-(4-(2-(1H-indazol-3-yl)vinyl)phenyl)(piperazin-1-yl)methanone; J-502761; [4-[2-(1H-Indazol-3-yl)ethenyl]phenyl]-1-piperazinylmethanone; [4-[(E)-2-(1H-indazol-3-yl)ethenyl]phenyl]-piperazin-1-ylmethanone; Methanone, (4-(2-(1H-indazol-3-yl)ethenyl)phenyl)-1-piperazinyl-; Methanone, [4-[2-(1H-indazol-3-yl)ethenyl]phenyl]-1-piperazinyl-; YYLKKYCXAOBSRM-JXMROGBWSA-N; (E)-(4-(2-(1H-Indazol-3-yl)vinyl)phenyl)(piperazin-1-yl)methanone hydrochloride; KW-2449 Hydrochloride; KW2449; MLS006011271; GTPL5691; SCHEMBL1596894; SCHEMBL1596897; CHEBI:91441; BCP02848; EX-A2306; BDBM50355496; MFCD18385006; s2158; KW-2449; ZINC43201999; AKOS027460993; BCP9000826; CS-0231; RL00013; SB19381; NCGC00346569-07; 841258-76-2; AC-28419; HY-10339; 1000669-72-6; SMR004703021; SW219852-1; X7371; W-5753; (E)-1-{4-[2-(1H-indazol-3-yl)vinyl]benzoyl}piperazine; 1000669-72-6 , KW 2449, KW-2449; 3-[(E)-2-[4-(piperazine-1-carbonyl)phenyl]ethenyl]-1H-indazole; Piperazine, 1-(4-((1E)-2-(1H-indazol-3-yl)ethenyl)benzoyl)-; (4-((1E)-2-(1H-Indazol-3-yl)ethenyl)phenyl)-1-piperazinylmethanone; 3-[(E)-2-{4-[(piperazin-1-yl)carbonyl]phenyl}ethenyl]-2H-indazole; KW 2449; 841259-17-4; D00ABO; cc-533; C20H20N4O; CID11427553; Tumor antigen-specific mAb (cancer), Kyowa; A10508; [4-[(1E)-2-(1H-Indazol-3-yl)ethenyl]phenyl]-1-piperazinylmethanone; [4-[(E)-2-(1H-indazol-3-yl)ethenyl]phenyl]-piperazin-1-yl-methanone; Tumor antigen-specific monoclonal antibody (cancer), Kyowa Hakko Kirin; KW2449; Tumor antigen-specific monoclonal antibody (cancer), Kyowa Hakko Kogyo; UNII-2D9N67F58G; CHEMBL1908397; 2D9N67F58G;